Yang Chao-Chun, Lee Ming-Hsueh, Liu Chia-Yen, Lin Meng-Hung, Yang Yao-Hsu, Chen Kuo-Tai, Huang Tsung-Yu
Department of Neurosurgery, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
Health Information and Epidemiology Laboratory, Chang Gung Memorial Hospital, Chiayi 61363, Taiwan.
J Fungi (Basel). 2024 Jan 12;10(1):61. doi: 10.3390/jof10010061.
Invasive fungal spondylodiscitis (IFSD) is rare and could be lethal in certain circumstances. The previous literature revealed limited data concerning its outcomes. This study aimed to establish a risk-scoring system to predict the one-year mortality rate of this disease. A total of 53 patients from a multi-centered database in Taiwan were included in this study. All the clinicopathological and laboratory data were retrospectively analyzed. Variables strongly related to one-year mortality were identified using a multivariate Cox proportional hazards model. A receiver operating characteristic (ROC) curve was used to express the performance of our IFSD scoring model. Five strong predictors were included in the IFSD score: predisposing immunocompromised state, the initial presentation of either radiculopathy or myelopathy, initial laboratory findings of WBC > 12.0 or <0.4 10/µL, hemoglobin < 8 g/dL, and evidence of candidemia. One-year mortality rates for patients with IFSD scores of 0, 1, 2, 3, and 4 were 0%, 16.7%, 56.3%, 72.7%, and 100%, respectively. The area under the curve of the ROC curve was 0.823. We developed a practical scoring model with easily obtained demographic, clinical, and laboratory parameters to predict the probability of one-year mortality in patients with IFSD. However, more large-scale and international validations would be necessary before this scoring model is commonly used.
侵袭性真菌性脊椎椎间盘炎(IFSD)较为罕见,在某些情况下可能致命。既往文献显示关于其预后的数据有限。本研究旨在建立一个风险评分系统来预测该疾病的一年死亡率。本研究纳入了来自台湾一个多中心数据库的53例患者。对所有临床病理和实验室数据进行回顾性分析。使用多变量Cox比例风险模型确定与一年死亡率密切相关的变量。采用受试者工作特征(ROC)曲线来表达我们的IFSD评分模型的性能。IFSD评分纳入了五个强预测因素:免疫功能低下的易感状态、神经根病或脊髓病的初始表现、白细胞初始实验室检查结果>12.0或<0.4×10⁹/µL、血红蛋白<8 g/dL以及念珠菌血症的证据。IFSD评分为0、1、2、3和4的患者一年死亡率分别为0%、16.7%、56.3%、72.7%和100%。ROC曲线下面积为0.823。我们开发了一个实用的评分模型,该模型具有易于获取的人口统计学、临床和实验室参数,以预测IFSD患者的一年死亡概率。然而,在该评分模型被广泛应用之前,还需要更多大规模的国际验证。